Ann: Uscom 2021 AGM Presentation, page-43

The USCOM 1A was approved for sale in the US market by the Food & Drug Administration (FDA) in February 2005, with CE Mark approval (for Europe, December 2003) and State Food & Drug Administration (now China FDA) approval for China (January 2004) following. Since then the product has received some major validation: it has been adopted as the standard of care at London’s Great Ormond Street Hospital for Children, the Kings College in London and the Paediatrics Department at the Pittsburgh University Medical Centre in the US. The International Space Station and the Russian space program both use the Uscom product to measure vascular and cardiac performance.